Clinical trial / 2012
Magnesium supplementation improved subjective sleep measures and altered serum renin, melatonin, and cortisol in elderly subjects.
In a double-blind randomized clinical trial, 46 elderly subjects received 500 mg magnesium or placebo daily for 8 weeks. Compared with placebo, magnesium supplementation brought about statistically significant increases in sleep time (P = 0.002), sleep efficiency (P = 0.03), serum renin (P < 0.001), and melatonin (P = 0.007). It also significantly decreased Insomnia Severity Index scores (P = 0.006), sleep onset latency (P = 0.02), and serum cortisol concentrations (P = 0.008), although total sleep time did not show a significant difference (P = 0.37).
- Study type
- Double-blind randomized clinical trial
- Who was studied
- 46 elderly subjects
- What was measured
- Insomnia severity index, sleep log measures, physical activity, and serum magnesium, renin, melatonin, and cortisol
THE PAPER
The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial.
Abbasi B, Kimiagar M, Sadeghniiat K, Shirazi MM, Hedayati M, Rashidkhani B. J Res Med Sci, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.